PROTAC CBP/P300 Degrader-1 is primarily utilized in the field of targeted protein degradation, specifically for research purposes. It is designed to degrade CBP and P300, which are transcriptional coactivators involved in various cellular processes. By selectively targeting these proteins, it helps in studying their roles in gene regulation, cell signaling, and disease pathways, particularly in cancer and other disorders linked to transcriptional dysregulation. This compound is a valuable tool in understanding the therapeutic potential of inhibiting or degrading these coactivators, aiding in the development of novel treatments for conditions where CBP and P300 are implicated.